Pharma Blog
Mastering the Art of Peak Integration in HPLC
Peak integration in High-Performance Liquid Chromatography (HPLC) is more than just a routine step—it’s the bridge between your experiment and the data-driven decisions that follow. Every peak tells a story, and accurate integration ensures you’re interpreting it correctly. Why is Peak Integration Crucial?The area under the curve (AUC) of a ... Read More
Effect of pH in Analytical Method
As a chromatographer not many of us are aware of how critical pH is in your method development, sometimes it is even considered as an inconsequential factor, which could have a negligible effect on our analysis. However, in truth pH can make or break your analysis, choosing the correct or ... Read More
Media and Buffers in Dissolution Method Development
Sink Conditions: Volume of medium should be at least 3 times that needed to form a saturated solution (USP definition). pH Range: Typical range is 1.1 to 6.8, but can be adjusted up to pH 8.0 for solubility. Common Buffers: Surfactants: Medium Deaeration: Ensure medium is deaerated to prevent bubbles, ... Read More
Powder Shape and Their Effect on Tablet Properties
The pharmaceutical industry relies heavily on powders for the formulation of solid dosage forms, particularly tablets. Powder properties, including particle size and shape, directly affect the manufacturing process and the performance of the final product. While particle size has been extensively studied, the influence of particle shape has garnered increasing ... Read More
Does an F2 Similarity Value of 50 Mean the Two Dissolution Profiles are Only 50% Similar?
No, the similarity factor (F2) is a mathematical representation of the quadratic mean difference between two dissolution profiles across all considered time points. An F2 value of 50 indicates that the two profiles differ by a small margin, with a mean difference of approximately 10%. The similarity factor is not ... Read More
Prevention or Delay of Diabetes | Standards of Care in Diabetes 2024
In people with prediabetes, monitor for the development of type 2 diabetes at least annually; modify based on individual risk assessment. Refer adults with overweight or obesity at high risk of DM2, as seen in the Diabetes Prevention Program (DPP), to an intensive lifestyle behavior change program to achieve and ... Read More
Mind Mapping Tool for Investigations
Mind mapping can be an incredibly effective tool in pharmaceutical investigations, helping teams structure their thinking, uncover connections, and generate insights systematically. Here’s how it can be applied effectively: Applications of Mind Mapping in Pharmaceutical Investigations Root Cause Analysis: During investigations of deviations, out-of-specification (OOS) results, or adverse events, mind ... Read More
Critical Material Attributes (CMAs) of Excipients
When focusing solely CMAs of excipients, the same principles of API apply. These attributes influence the performance and manufacturability of the final drug product and are critical for achieving consistency in pharmaceutical formulations. Critical Material Attributes of Excipients Physical Properties Particle Size Distribution (PSD): Bulk Density and Tap Density: Specific ... Read More
Discriminating Dissolution Media
Discriminating Dissolution Media is a critical component in pharmaceutical formulation development, designed to identify differences in the dissolution performance of drug products. These media are particularly useful when addressing formulation changes, variations in API properties, or manufacturing process alterations. Key Features of a Discriminating Dissolution Medium Examples of Common Discriminating ... Read More
Reference Standard (RS) in Bioequivalence Studies
Introduction In pharmaceutical development, a Reference Standard (RS), often referred to as a Reference Listed Drug (RLD) or comparator product, is a benchmark for evaluating the performance of generic drugs in bioequivalence (BE) studies. The RS ensures that generic drugs meet therapeutic equivalence standards, a critical step for regulatory approval. ... Read More
Alcohol Dose Dumping | A Critical Pharmaceutical Challenge
Introduction Alcohol dose dumping occurs when controlled-release formulations release their active ingredient rapidly in the presence of alcohol. This unintended release can lead to elevated drug levels, increasing risks of toxicity, side effects, or overdose. Mechanisms of Alcohol Dose Dumping Drugs at Risk Clinical Implications Preventive Measures Patient Strategies Regulatory ... Read More